Charlie Deason
Director, Healthcare IT
About Mr. Deason
Charlie Deason is a director for William Blair based in the firm’s Charlotte office. He joined William Blair’s investment banking team in 2021. Prior to William Blair, he worked for SunTrust Robinson Humphrey / Truist Securities, Cotiviti, and Oppenheimer & Co.
Notable Transactions
- HSTechnology - sale to MultiPlan
- eVisit - growth capital raise
- Nuvem - recapitalization by Parthenon Capital Partners
- Healthcare Payment Specialists - sale to TransUnion
- Cotiviti - acquisition of RowdMap
- Connolly - merger with iHealth Technologies
- Connolly - sale to Advent International
- Medica HealthCare Plans - sale to UnitedHealth Group
Rigorous pursuit of your success. Every transaction. Every time.
Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William Blair
Healthcare IT
As technology becomes an increasingly critical part of the effort to reduce healthcare costs, increase efficiency, and improve patient outcomes, we are committed to helping innovative healthcare IT companies accelerate their growth by accessing capital and forming strategic partnerships.
Learn more about our healthcare IT expertise
About William Blair
William Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*
Year William Blair was founded
Employees worldwide
Client assets
Independent and employee-owned
Offices worldwide
Companies under coverage
As of March 31, 2022
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.